Details for Patent: 6,677,358
✉ Email this page to a colleague
Summary for Patent: 6,677,358
| Title: | NIDDM regimen |
| Abstract: | The present invention discloses a regimen for the treatment of type 2 diabetes, in which the endogenous secretion of insulin is stimulated in connection with meals, by administering a short-acting, oral hypoglycemic agent. Also, the present invention discloses a method of achieving improvement in glycemic control by combined use of repaglinide and metformin in NIDDM patients poorly controlled on metformin alone. |
| Inventor(s): | Muller; Peter Gi.o slashed.rtz (Princeton Junction, NJ) |
| Assignee: | Novo Nordisk A/S (Bagsvaerd, DK) |
| Application Number: | 09/459,526 |
|
Patent Claim Types: see list of patent claims | Composition; Dosage form; Use; Device; |
Drugs Protected by US Patent 6,677,358
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 6,677,358
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Denmark | 0694/97 | Jun 13, 1997 |
International Family Members for US Patent 6,677,358
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 201139 | ⤷ Try a Trial | |||
| Australia | 7906898 | ⤷ Try a Trial | |||
| Germany | 69800806 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
